ArticleTherapeutic advances in medical oncology2021

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.

Oliver Illini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.